WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 157 filers reported holding WUXI PHARMATECH CAYMAN INC in Q3 2014. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $174,000 | -77.5% | 5,300 | -74.8% | 0.01% | -77.8% |
| Q1 2014 | $774,000 | -44.8% | 21,000 | -42.5% | 0.04% | -45.1% |
| Q4 2013 | $1,401,000 | +57.4% | 36,500 | +12.3% | 0.08% | +39.0% |
| Q3 2013 | $890,000 | +25.0% | 32,500 | -4.1% | 0.06% | +11.3% |
| Q2 2013 | $712,000 | – | 33,900 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coupland Cardiff Asset Management LLP | 449,361 | $15,737,000 | 15.66% |
| Sloane Robinson LLP | 120,000 | $4,202,000 | 6.01% |
| Black Creek Investment Management Inc. | 869,173 | $30,438,000 | 3.50% |
| Grandeur Peak Global Advisors, LLC | 358,385 | $12,551,000 | 3.05% |
| THOMAS WHITE INTERNATIONAL LTD | 538,212 | $18,848,000 | 2.73% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 88,460 | $3,098,000 | 1.39% |
| Granite Point Capital Management, L.P. | 70,000 | $2,451,000 | 1.22% |
| COMMONWEALTH BANK OF AUSTRALIA | 2,626,749 | $91,989,000 | 1.19% |
| Apex Capital Management | 1,048,531 | $36,720,000 | 1.11% |
| Pier Capital, LLC | 196,369 | $6,877,000 | 1.10% |